Zak Mir takes a charting look at the USA Chartbreakers – Friday 10th October 2025

Zak Mir takes a charting look at S&P 500, Nasdaq 100, AtlasClear, Baosheng, Biodexa, Bluejay, New Era Helium, 9F, Pyxis, SEALSQ, Traws.

Below, I walk through the big-picture S&P 500 and Nasdaq 100 setups, then run through the individual charts I’m watching today: AtlasClear, Baosheng, Biodexa, Bluejay Diagnostics, New Era Helium, 9F, Pyxis, SEALSQ, SU Group and Traws. Expect levels, key trendlines, RSI signals and practical target/support zones to watch over the coming weeks.

As always, do your own research and treat these as chart-based observations rather than hard recommendations.

Market overview

S&P 500

The S&P remains inside the rising trend channel that began in April after the tariff-induced sell‑off. The channel floor sits roughly at the 50‑day moving average (6,525), which I view as the “worst” level to hold. There is a mild bearish divergence (higher highs in price while RSI traces slightly lower), but RSI is still well above its uptrend line and price sits comfortably above the prior resistance around 6,700.

Outlook: bullish while above 6,700. I’m looking for a move toward 6,900+ by the end of next month. If momentum stalls, consolidation into the mid 6,500s would be a reasonable alternative.

Nasdaq 100

The Nasdaq has been faithful to its April rising trend channel. The near‑term target is 25,600, which looks achievable by the end of this month provided we remain on the right side of the channel floor and above the 50‑day line, just below 24,000.

Upside extension: if we get a fresh upside spike the red January resistance projection around 26,400–26,500 is the next zone to watch — potentially by the end of next month while the market stays above 24,000.

Stocks I’m watching

Below are the individual setups I discussed, with the technical triggers, support levels and my targets (mostly measured to the top of channels/ranges over the next few weeks).

AtlasClear Holdings, Inc. (ATCH)

Situation: After a breakout above a rising channel we saw a rug‑pull that retraced back to the channel floor and the 50‑day ($0.39). That retest coincided with a classic bear‑trap/island reversal — a gap down to a near‑term low followed by a gap up.

Key levels: hold the 50‑day ($0.39) on an end‑of‑day basis. A short‑term gap fill target is $0.65, with a larger target up at the top of the channel near $0.93 by the end of next month if the bullish thesis holds.

“”A bear trap island reversal suggests the bears have been caught out — we could at least try and fill that gap up to $0.65 in coming days.””

Baosheng Media Group Holdings Limited (BAOS)

Situation: The shares have gapped up through the $5–6 area and look set to challenge the top of the range. What’s encouraging is multiple RSI bounces at or above neutral 50 — a pattern that can precede sustained upside runs.

Key levels: stay on the right side of $4. If momentum holds the range high around $7–8 is the obvious target.

Biodexa Pharmaceuticals Plc (BDRX)

Situation: In a clear rising trend channel; multiple RSI 50+ rebounds since late last month add conviction to the move.

Key levels: maintaining above the broken late‑July resistance near $9.40 is important. If that holds, I’m targeting the top of the channel around $15.50 by the end of next month.

Bluejay Diagnostics, Inc. (BJDX)

Situation: A volatile setup that recently hit the top of a broadening triangle ($3). RSI has bounced above 50 recently — another positive signal.

Key levels: keep an eye on the 200‑day line ($2.47). Above that look for the upper parallel of the triangle near $5.16 by the end of next month.

New Era Energy & Digital, Inc. (NUAI)

Situation: Helium names can be tricky, but this one has now hit the top of a rising trend channel toward $3.20. Breaking and closing above that on an end‑of‑day basis would be constructive.

Key levels: September resistance broken at $2.65 — staying above that gives an attractive risk/reward. Target: $5 by the end of next month if the breakout confirms.

9F Inc. (JFU)

Situation: A strong breakout driven by a triple RSI 50+ rebound. That RSI action was the early indicator of this move.

Key levels: above the recent resistance at $3.26 opens the path to $7 by the end of next month if momentum continues.

Pyxis Oncology, Inc. (PYXS)

Situation: Chart pattern closely mirrors previous breakouts and features RSI 50 rebounds from last month (and higher ones since August). This suggests a higher probability of a sustained advance.

Key levels: maintain above yesterday’s support and the prior support from Sep/Oct last year near $3. Target: top of the channel near $6.60 by the end of next month.

SEALSQ Corp (LAES)

Situation: A neat breakout with RSI bouncing above neutral several times and price finding support at the old resistance zone ($4.50).

Key levels: above $4.50 look for the range top around $8.70 — possibly as soon as the end of this month, though end of next month is the conservative timeline.

SU Group Holdings Limited (SUGP)

Situation: A choppy ride recently, but the shares gapped through the 200‑day after bouncing off a rising 50‑day — a constructive sequence you see often when a bigger leg up begins.

Key levels: 200‑day sits near $7.84; above that the top of the range and channel base is around $16 by the end of next month. For risk control some traders may use the nearby resistance‑turned‑support at $9.30 as a stop zone.

Traws Pharma, Inc. (TRAW)

Situation: Another rising trend channel with multiple RSI 50 rebounds in recent sessions. The break of the 200‑day ($3.10) could be lasting if the RSI pattern continues to hold.

Key levels: yesterday’s support near $2.52 on an end‑of‑day basis is important to hold. Target: top of the channel near $4.80 — potentially by the end of this month if momentum accelerates.

Putting it together — risk, timelines and what I’m watching

  • Timeframes: most targets are priced to the top of channels/ranges by the end of next month, with a few names that could run as soon as the end of this month if momentum is strong.
  • RSI 50 rebounds: I repeatedly referenced RSI bouncing at or above 50 — I treat repeated RSI 50+ rebounds as a practical signal for an underlying trend shift toward sustainable upside.
  • Moving averages: the 50‑ and 200‑day moving averages are critical support references. End‑of‑day closes above/below these lines inform whether a setup stays valid.
  • Risk management: use the logical support zones mentioned (broken resistances, 50/200‑day lines, recent support levels) as stop or re‑assessment points; adjust position size accordingly.

Conclusion

The overall market tone remains constructive: S&P and Nasdaq are inside rising channels and several individual names have the technical ingredients for further gains — multiple RSI 50 rebounds, retests of moving averages and clean breakouts. Keep an eye on the specific support lines I flagged (50/200‑day, broken resistances and recent supports) and monitor end‑of‑day closes for confirmation.

I’ll share more updates over the weekend as price action evolves. Trade carefully and let the technicals guide your risk decisions.

Disclaimer & Declaration of Interest:

The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.


Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned